High frequency and diversity of parechovirus A in a cohort of Malawian children.


Journal

Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 09 08 2018
accepted: 28 11 2018
pubmed: 23 1 2019
medline: 6 3 2019
entrez: 23 1 2019
Statut: ppublish

Résumé

Parechoviruses (PeVs) are highly prevalent viruses worldwide. Over the last decades, several studies have been published on PeV epidemiology in Europe, Asia and North America, while information on other continents is lacking. The aim of this study was to describe PeV circulation in a cohort of children in Malawi, Africa. A total of 749 stool samples obtained from Malawian children aged 6 to 60 months were tested for the presence of PeV by real-time PCR. We performed typing by phylogenetic and Basic Local Alignment Search Tool (BLAST) analysis. PeV was found in 57% of stool samples. Age was significantly associated with PeV positivity (p = 0.01). Typing by phylogenetic analysis resulted in 15 different types, while BLAST typing resulted in 14 different types and several indeterminate strains. In total, six strains showed inconsistencies in typing between the two methods. One strain, P02-4058, remained untypable by all methods, but appeared to belong to the recently reclassified PeV-A19 genotype. PeV-A1, -A2 and -A3 were the most prevalent types (26.8%, 13.8% and 9.8%, respectively). Both the prevalence and genetic diversity found in our study were remarkably high. Our data provide an important contribution to the scarce data available on PeV epidemiology in Africa.

Identifiants

pubmed: 30666460
doi: 10.1007/s00705-018-04131-7
pii: 10.1007/s00705-018-04131-7
pmc: PMC6394728
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-806

Références

J Clin Microbiol. 2004 Jul;42(7):3059-64
pubmed: 15243060
Clin Infect Dis. 2006 Jan 15;42(2):204-10
pubmed: 16355330
J Clin Microbiol. 1990 Mar;28(3):495-503
pubmed: 1691208
Emerg Infect Dis. 2006 Oct;12(10):1572-5
pubmed: 17176575
PLoS Pathog. 2007 Dec;3(12):e191
pubmed: 18085822
N Engl J Med. 2008 Feb 28;358(9):888-99
pubmed: 18305266
J Clin Microbiol. 2008 Sep;46(9):2884-9
pubmed: 18614653
J Clin Microbiol. 2008 Oct;46(10):3446-53
pubmed: 18753351
J Clin Microbiol. 2008 Dec;46(12):3965-70
pubmed: 18945833
BMC Infect Dis. 2009 Aug 23;9:136
pubmed: 19698184
J Gen Virol. 2010 Jan;91(Pt 1):145-54
pubmed: 19759239
J Clin Virol. 2010 Jul;48(3):202-7
pubmed: 20472496
J Clin Microbiol. 2010 Aug;48(8):2683-8
pubmed: 20519478
Pediatr Infect Dis J. 2011 Mar;30(3):238-42
pubmed: 20948454
J Clin Microbiol. 2012 Dec;50(12):4111-3
pubmed: 23015672
J Clin Microbiol. 2013 Mar;51(3):759-70
pubmed: 23254123
Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1525-31
pubmed: 23780695
J Clin Virol. 2013 Sep;58(1):205-10
pubmed: 23810613
PLoS One. 2013 Jul 03;8(7):e68321
pubmed: 23844186
J Clin Virol. 2013 Sep;58(1):211-5
pubmed: 23891146
Pediatr Infect Dis J. 2014 Apr;33(4):e87-91
pubmed: 24104958
Arch Virol. 2014 May;159(5):971-7
pubmed: 24221251
Emerg Infect Dis. 2014 Jan;20(1):83-7
pubmed: 24377661
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
J Clin Virol. 2014 Jun;60(2):84-9
pubmed: 24690382
Euro Surveill. 2014 Apr 17;19(15):null
pubmed: 24762664
Clin Infect Dis. 2015 Jan 15;60(2):228-36
pubmed: 25301212
BMC Infect Dis. 2015 Feb 25;15:95
pubmed: 25879805
J Clin Virol. 2015 Oct;71:40-3
pubmed: 26370313
J Pediatric Infect Dis Soc. 2012 Jun;1(2):136-43
pubmed: 26619166
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
J Med Virol. 2017 Mar;89(3):435-442
pubmed: 27505281
Epidemiol Infect. 2016 Dec;144(16):3451-3460
pubmed: 27571735
Microbiol Immunol. 2016 Dec;60(12):854-858
pubmed: 27925289
An Pediatr (Barc). 2018 Feb;88(2):82-88
pubmed: 28365283
J Pediatric Infect Dis Soc. 2018 May 15;7(2):104-112
pubmed: 28369502
PLoS One. 2017 Sep 8;12(9):e0184533
pubmed: 28886185
J Clin Virol. 2017 Nov;96:116-119
pubmed: 29055866
J Gen Virol. 2017 Nov;98(11):2699-2711
pubmed: 29106347
Epidemiol Infect. 2018 Jan;146(1):11-18
pubmed: 29173223
Pediatr Int. 2018 Feb;60(2):142-147
pubmed: 29205679
Arch Virol. 2018 Oct;163(10):2645-2653
pubmed: 29808442
Emerg Infect Dis. 2019 Jan;25(1):148-152
pubmed: 30561318

Auteurs

Lieke Brouwer (L)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. Lieke.brouwer@amc.uva.nl.

Eveliina Karelehto (E)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Alvin X Han (AX)

Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Laboratory of Applied Evolutionary Biology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Xiomara V Thomas (XV)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Andrea H L Bruning (AHL)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Job C J Calis (JCJ)

Department of Pediatric Intensive Care, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Michaël Boele van Hensbroek (MB)

Department of Pediatric Intensive Care, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Brenda M Westerhuis (BM)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.
Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.

Darsha Amarthalingam (D)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Sylvie M Koekkoek (SM)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Sjoerd P H Rebers (SPH)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Kamija S Phiri (KS)

School of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.

Katja C Wolthers (KC)

Department of Medical Microbiology, Laboratory of Clinical Virology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Dasja Pajkrt (D)

Department of Pediatric Intensive Care, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH